Application 020741
- Type
- NDA
- Sponsor
- GEMINI LABS LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PRANDIN | REPAGLINIDE | TABLET;ORAL | 0.5MG | Yes | No |
| 002 | PRANDIN | REPAGLINIDE | TABLET;ORAL | 1MG | Yes | No |
| 003 | PRANDIN | REPAGLINIDE | TABLET;ORAL | 2MG | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020741-001 | PRANDIN | REPAGLINIDE | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | |
| N020741-002 | PRANDIN | REPAGLINIDE | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | |
| N020741-003 | PRANDIN | REPAGLINIDE | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2020-11-12 02:37 UTC | 2020-11 | N020741-003 | PRANDIN | 2MG | TABLET / ORAL | RLD | 1997-12-22 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020741-001 | PRANDIN | 0.5MG | TABLET / ORAL | RLD | 1997-12-22 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020741-002 | PRANDIN | 1MG | TABLET / ORAL | RLD | 1997-12-22 | 3f01610625f2… | |
| 2019-12-14 00:12 UTC | 2019-12 | N020741-003 | PRANDIN | 2MG | TABLET / ORAL | RLD | 1997-12-22 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020741-001 | PRANDIN | 0.5MG | TABLET / ORAL | RLD | 1997-12-22 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020741-002 | PRANDIN | 1MG | TABLET / ORAL | RLD | 1997-12-22 | b00525d2431f… | |
| 2019-09-15 20:21 UTC | 2019-09 | N020741-003 | PRANDIN | 2MG | TABLET / ORAL | RLD | 1997-12-22 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020741-001 | PRANDIN | 0.5MG | TABLET / ORAL | RLD | 1997-12-22 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020741-002 | PRANDIN | 1MG | TABLET / ORAL | RLD | 1997-12-22 | ea99ee380514… | |
| 2019-07-19 19:46 UTC | 2019-07 | N020741-003 | PRANDIN | 2MG | TABLET / ORAL | RLD | 1997-12-22 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 6a51e52b5d6a… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 1c564ffb4f44… | |
| 2024-02-18 07:12 UTC | 2024-02 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | ea1830bbd6c7… | |
| 2023-12-20 04:57 UTC | 2023-12 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | a72a2bbeb626… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 9b2671bbb829… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | a67488948f0b… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3f0d92c62455… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 053a50430f4f… | |
| 2023-05-13 08:27 UTC | 2023-05 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3bdfa0b2c4d7… | |
| 2023-01-26 05:58 UTC | 2023-01 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020741-001 | PRANDIN | 0.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020741-002 | PRANDIN | 1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3a93d1ddd44b… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020741-003 | PRANDIN | 2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET / ORAL | RLD | 1997-12-22 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 6ae28683-28cc-408e-90f9-6a3dddfc668d | 2025-11-04 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | NorthStar RxLLC | 7f3118ce-fcbb-4f8b-b1ba-d8cd95e5b665 | 2025-09-15 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | d85abce4-16da-4231-b28a-6afca04ebf68 | 2025-06-05 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Chartwell RX, LLC | cb995e92-295e-4638-a064-978211f5afe1 | 2025-05-02 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 9f2006d9-e0c0-4cc4-b2c9-84b7d9f77173 | 2025-01-23 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Bryant Ranch Prepack | 3b150917-e2fd-4366-af83-ebc1d7297ca9 | 2025-01-16 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | American Health Packaging | dd1d8337-9903-4b8a-a9ea-569e4d134e74 | 2024-10-22 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Aurobindo Pharma Limited | 68064989-47ea-4ed5-a20e-43c4ef6ec271 | 2024-05-14 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Rising Pharma Holdings, Inc. | d7673e22-0dbb-4395-ad60-943d249203a1 | 2024-05-14 | Warnings, Adverse reactions | REPAGLINIDE |
| Repaglinide | REPAGLINIDE | Macleods Pharmaceuticals Limited | 7a93246c-9323-40c4-b590-a40dcb133c8c | 2023-04-04 | Warnings, Adverse reactions | REPAGLINIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0169-0081 | Prandin | repaglinide | Novo Nordisk | NDA | Current |
| 0169-0082 | Prandin | repaglinide | Novo Nordisk | NDA | Current |
| 0169-0084 | Prandin | repaglinide | Novo Nordisk | NDA | Current |
| 68151-3565 | Prandin | repaglinide | Carilion Materials Management | NDA | Current |
| 68151-3566 | Prandin | repaglinide | Carilion Materials Management | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 57515 | SUPPL | 2019-02-13 |
| 57327 | SUPPL | 2019-01-23 |
| 57326 | ORIG | 2019-01-23 |
| 47153 | SUPPL | 2017-02-09 |
| 47152 | SUPPL | 2017-02-09 |
| 47145 | SUPPL | 2017-02-09 |
| 47144 | SUPPL | 2017-02-09 |
| 13325 | SUPPL | 2012-03-06 |
| 3244 | SUPPL | 2012-03-05 |
| 3243 | SUPPL | 2010-08-03 |
| 13324 | SUPPL | 2010-07-31 |
| 35253 | SUPPL | 2009-06-22 |
| 3242 | SUPPL | 2009-06-16 |
| 13323 | SUPPL | 2008-07-15 |
| 3241 | SUPPL | 2008-07-15 |
| 41637 | SUPPL | 2007-07-06 |
| 41636 | SUPPL | 2007-07-06 |
| 41635 | SUPPL | 2007-07-06 |
| 20893 | SUPPL | 2007-07-06 |
| 20892 | SUPPL | 2007-07-06 |
| 3240 | SUPPL | 2006-06-28 |
| 13322 | SUPPL | 2005-02-11 |
| 3239 | SUPPL | 2005-02-11 |
| 3238 | SUPPL | 2003-10-17 |
| 25668 | SUPPL | 2003-08-29 |
| 13321 | SUPPL | 2003-08-29 |
| 25667 | SUPPL | 2002-10-21 |
| 13320 | SUPPL | 2002-10-21 |
| 13319 | SUPPL | 2002-01-18 |
| 3237 | SUPPL | 2002-01-18 |